Anti-FUT10/ FUCTX functional antibody

Anti-FUT10/ FUCTX functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FUT10/FUT10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0226-Ab-1/ GM-Tg-hg-SE0226-Ab-2Anti-Human FUT10 monoclonal antibodyHuman
GM-Tg-rg-SE0226-Ab-1/ GM-Tg-rg-SE0226-Ab-2Anti-Rat FUT10 monoclonal antibodyRat
GM-Tg-mg-SE0226-Ab-1/ GM-Tg-mg-SE0226-Ab-2Anti-Mouse FUT10 monoclonal antibodyMouse
GM-Tg-cynog-SE0226-Ab-1/ GM-Tg-cynog-SE0226-Ab-2Anti-Cynomolgus/ Rhesus macaque FUT10 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0226-Ab-1/ GM-Tg-felg-SE0226-Ab-2Anti-Feline FUT10 monoclonal antibodyFeline
GM-Tg-cang-SE0226-Ab-1/ GM-Tg-cang-SE0226-Ab-2Anti-Canine FUT10 monoclonal antibodyCanine
GM-Tg-bovg-SE0226-Ab-1/ GM-Tg-bovg-SE0226-Ab-2Anti-Bovine FUT10 monoclonal antibodyBovine
GM-Tg-equg-SE0226-Ab-1/ GM-Tg-equg-SE0226-Ab-2Anti-Equine FUT10 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0226-Ab-1/ GM-Tg-hg-SE0226-Ab-2; GM-Tg-rg-SE0226-Ab-1/ GM-Tg-rg-SE0226-Ab-2;
GM-Tg-mg-SE0226-Ab-1/ GM-Tg-mg-SE0226-Ab-2; GM-Tg-cynog-SE0226-Ab-1/ GM-Tg-cynog-SE0226-Ab-2;
GM-Tg-felg-SE0226-Ab-1/ GM-Tg-felg-SE0226-Ab-2; GM-Tg-cang-SE0226-Ab-1/ GM-Tg-cang-SE0226-Ab-2;
GM-Tg-bovg-SE0226-Ab-1/ GM-Tg-bovg-SE0226-Ab-2; GM-Tg-equg-SE0226-Ab-1/ GM-Tg-equg-SE0226-Ab-2
Products NameAnti-FUT10 monoclonal antibody
Formatmab
Target NameFUT10
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FUT10 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0226-Ag-1Recombinant multi-species FUT10/ FUCTX protein


    Target information

    Target IDGM-SE0226
    Target NameFUT10
    Gene ID84750,171167,497619,697659,503548,101097389,360195,100061170
    Gene Symbol and Synonymsfuc-TX,FUCTX,FUT10,fut10A
    Uniprot AccessionQ6P4F1,Q5F2L1,Q5F2N4,Q6A198
    Uniprot Entry NameFUT10_HUMAN,FUT10_RAT,FUT10_CANLF,FUT10_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000172728
    Target ClassificationN/A

    The target: FUT10, gene name: FUT10, also named as FUCTX. Predicted to enable alpha-(1->3)-fucosyltransferase activity. Predicted to be involved in fucosylation. Predicted to act upstream of or within cerebral cortex radially oriented cell migration and neuronal stem cell population maintenance. Located in Golgi apparatus; endoplasmic reticulum; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.